STELARA (ustekinumab) is a new biologic option, now TGA approved, for the treatment of Crohn’s disease. Please join us to hear Professor Subrata Ghosh (UK) explain the role of IL12/23 and share his experience using STELARA in patients with Crohn’s disease. The meeting will be chaired by Professor Michael Kamm and will feature expert panellists experienced in the use of STELARA. The symposium will be held in collaboration with GESA's Australian Gastroenterology Week (AGW).
Registration
Register online now by clicking on the button below. Places are limited. Registrations close Friday, 11 August 2017.
| Saturday, 19 August 2017 |
| Grand Ballroom |
| Sofitel Gold Coast Broadbeach |
| 81 Surf Parade, Broadbeach QLD |
| Location Map |
Registration
Register online now by clicking on the button below. Places are limited. Registrations close Friday, 11 August 2017.
Conference Secretariat
For event related questions or enquiries please contact JC Events by clicking here.
Partners: In accordance with the Code of Conduct for the prescription medicines industry in Australia, any costs (for example travel or meals) incurred by a partner/spouse, guest or family member travelling with a healthcare professional must not be paid for or subsidised by the company.
Privacy Statement: We collect your personal information to process your registration for this Janssen event and for related administrative purposes. Without this information we are unable to process your registration. Your personal information may also be processed by our contracted services providers who assist us from time to time with event management. Subject to some exceptions permitted by law you may request access to, or correction of, your personal information. For further information about our privacy practices please go to www.janssen.com.au/privacy.
©Janssen 2017. ®Registered trademark of Janssen-Cilag Pty Ltd. ABN 47 000 129 975. 1–5 Khartoum Road, Macquarie Park NSW 2113 Australia.
Telephone 1800 226 334. MKT-STE-AU-0159. McCann Health 10777557. June 2017.
Privacy Statement: We collect your personal information to process your registration for this Janssen event and for related administrative purposes. Without this information we are unable to process your registration. Your personal information may also be processed by our contracted services providers who assist us from time to time with event management. Subject to some exceptions permitted by law you may request access to, or correction of, your personal information. For further information about our privacy practices please go to www.janssen.com.au/privacy.
©Janssen 2017. ®Registered trademark of Janssen-Cilag Pty Ltd. ABN 47 000 129 975. 1–5 Khartoum Road, Macquarie Park NSW 2113 Australia.
Telephone 1800 226 334. MKT-STE-AU-0159. McCann Health 10777557. June 2017.
